Evidence map›Paper›PMID 42176837›Full record

ArticleContraception2026

Socio-behavioral factors linked to willingness to use new male contraceptives: A cross-sectional survey of men and female partners across four low- and middle-income countries.

Brian T Nguyen, Nancy Kidula, Nathalie Kapp, Khurshed Nosirov, Mohamed Mahmoud Ali, Abdellatif Maamri, Kwasi Adu Manu, Kojo Asamoah Boateng, Marcela Sánchez, Paola C Montenegro and 2 more

Abstract read
In one paragraph

Article in Contraception, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Brian T NguyenKeck School of Medicine of the University of Southern California, California, CA, United States. Electronic address: nguyenbt@usc.edu.
Nancy KidulaThe UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.
Nathalie KappInternational Planned Parenthood Federation, London, UK.
Khurshed NosirovThe UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.
Mohamed Mahmoud AliThe UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.
Abdellatif MaamriAssociation Marocaine de Planification Familiale/UMPO.
Kwasi Adu ManuPlanned Parenthood Association of Ghana.
Kojo Asamoah BoatengPlanned Parenthood Association of Ghana.
Marcela SánchezProfamilia, Colombia.
Paola C MontenegroProfamilia, Colombia.
Koffi E DzotsiAssociation Togolaise pour le Bien-Etre Familial.
James KiarieThe UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNumerous population-level surveys support willingness to use new male contraceptives (MC) among men and their female partners across a range of cultures and geographies, despite unproven efficacy and uncertain risk. Whether such willingness is related to attitudes about gender equity and/or key reproductive experiences warrants further exploration. We explore socio-behavioral factors linked to variations in willingness to use new MCs in Colombia, Ghana, Morocco, and Togo. STUDY

designWe conducted approximately two thousand surveys examining new MC attitudes with sexually active, reproductive age (18-50 years) men and their female sexual partners, recruited from both clinic and community settings from July-September 2023. We additionally collected socio-demographics, reproductive histories, and contraceptive attitudes and behaviors, examining their associations with willingness to use new MCs via regression modeling.

resultsNearly 75% (72.3% male, 76.2% female partners; n = 1444/1945) of survey respondents reported willingness to use new MCs. Willingness ranged from 69.4% in Togo to 82.2% in Colombia. Factors independently linked to willingness to use new MCs among men included having multiple current sex partners and having been involved in an unintended pregnancy; those for female partners included wanting to avoid pregnancy, and current use of or desire for contraception. For both partners, willingness to use new MCs was linked to increasing gender equitable attitudes.

conclusionsRegardless of gender, geography, class, culture, and reproductive experience, the significant association of gender equitable attitudes on willingness to use new male contraceptives suggests a potential role for gender equity initiatives to increase their uptake when available. IMPLICATIONS: Our findings both broaden and deepen published support for new MC development worldwide. Regardless of variations in culture and social norms across populations, our findings emphasize the influence of the individual's desire to avoid an unwanted pregnancy and gender-equitable attitudes.

Indexed as

Contraception BehaviorContraceptive Agents, MaleHealth Knowledge, Attitudes, PracticeSexual PartnersAdolescentAdultColombiaCross-Sectional StudiesDeveloping CountriesFemaleGhanaHumansMaleMiddle AgedMoroccoSexual BehaviorContraceptive Agents, MaleGenderMale contraceptionMen’s healthMen’s reproductive health

Identifiers

PMID42176837
PMCPMC7619453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.